Phosphorylation by Aurora‐A kinase and ubiquitination by MDM2 contribute to proteasome‐mediated degradation of SETD2 in advanced‐phase CML. This evidence concerns the gene SETD2 and chronic myelogenous leukemia, BCR-ABL1 positive.